-
1by Fatemeh Sadat Hosseini, Alireza Malektojari, Sara Ghazizadeh, Mehdi Hassaniazad, Parivash Davoodian, Habib Dadvand, Amin Reza Nikpoor, Sara Nikoofal-Sahlabadi, Sara Kahoori, Mojtaba Sepandi, Soheil Hassanipour, Mohammad Fathalipour“... and moderately severe COVID-19. Trial design This is a phase 3, single-center, randomized, open-label, controlled...”
Published 2021-01-01
Get full text
Article